55 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Foghorn Therapeutics Competitors or Alternatives

Foghorn Therapeutics's top competitors include Arvinas, Kymera and Nurix.

Unlock 7 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Foghorn Therapeutics's company profile

Adrian Gottschalk

President & CEO

80/100
120
$306.6M
$22.6M
  • $306.6M
    $22.6M
  • 120
    $306.6M
  • $22.6M
  • 80/100
  • 120
  • $306.6M
  • $22.6M
View ProfileView
1
Foghorn Therapeutics's Competitor - Arvinas logo

John G. Houston

President & CEO

90/100
420
$268.4M
$263.4M
  • $268.4M
    $263.4M
  • 420
    $268.4M
  • $263.4M
  • 90/100
  • 420
  • $268.4M
  • $263.4M
View ProfileView
2
Foghorn Therapeutics's Competitor - Kymera logo

Nello Mainolfi

President & CEO

88/100
170
$1.1B
$47.1M
  • $1.1B
    $47.1M
  • 170
    $1.1B
  • $47.1M
  • 88/100
  • 170
  • $1.1B
  • $47.1M
View ProfileView
3
Foghorn Therapeutics's Competitor - Nurix logo

Arthur T. Sands

President & CEO

91/100
300
$733.6M
$56.4M
  • $733.6M
    $56.4M
  • 300
    $733.6M
  • $56.4M
  • 91/100
  • 300
  • $733.6M
  • $56.4M
View ProfileView
4
Foghorn Therapeutics's Competitor - Vividion logo

Aleksandra Rizo

President & CEO

84/100
100 - 250
$371.5M
$25M - 100M
  • $371.5M
    $25M - 100M
  • 100 - 250
    $371.5M
  • $25M - 100M
  • 84/100
  • 100 - 250
  • $371.5M
  • $25M - 100M
View ProfileView
5
Foghorn Therapeutics's Competitor - Cedilla logo

Alexandra Glucksmann

President & CEO

90/100
25 - 100
$138.8M
$100K - 5M
  • $138.8M
    $100K - 5M
  • 25 - 100
    $138.8M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $138.8M
  • $100K - 5M
View ProfileView
The top 10 competitors in Foghorn Therapeutics' competitive set are Arvinas, Kymera, Nurix, C4T, Vividion, Cedilla, IFM Therapeutics, Axial Therapeutics, Voyager and Enlivex. Together they have raised over 3.9B between their estimated 1.4K employees. Foghorn Therapeutics has 120 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 142.

Foghorn Therapeutics VS Arvinas

Arvinas is Foghorn Therapeutics's top competitor. Arvinas is a Public company that was founded in New Haven, Connecticut in 2013. Arvinas operates in the Biotechnology industry. Arvinas has 300 more employees vs. Foghorn Therapeutics.

Foghorn Therapeutics VS Kymera

Kymera has been one of Foghorn Therapeutics's top competitors. Kymera is headquartered in Watertown, Massachusetts, and was founded in 2015. Kymera is in the Biotechnology field. Kymera generates 208% the revenue of Foghorn Therapeutics.

Foghorn Therapeutics VS Nurix

Nurix is perceived as one of Foghorn Therapeutics's biggest rivals. Nurix was founded in 2009 in San Francisco, California. Nurix competes in the Biotechnology field. Nurix generates $33.8M more revenue than Foghorn Therapeutics.

Looking for similar companies to Foghorn Therapeutics?

Similar Companies

Biotechnology companies in Cambridge

See 561 companies 
Companies in Cambridge with employees in 100-250 range

See 737 companies 
Pharmaceuticals & Biotechnology companies in Cambridge

See 700 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 
Biotechnology companies in Massachusetts

See 1,343 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,717 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,805 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Foghorn Therapeutics and Foghorn Therapeutics's Competitors

April 17, 2025centralcharts
Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q...

Frequently Asked Questions about Foghorn Therapeutics

  1. Who are Foghorn Therapeutics's top competitors?

    Foghorn Therapeutics's top 3 competitors are Arvinas, Kymera, Nurix.

  2. Who is similar to Foghorn Therapeutics?

    Arvinas is the most similar to Foghorn Therapeutics. Kymera and Nurix are also similar to Foghorn Therapeutics.

  1. Are Foghorn Therapeutics and Arvinas competitors?

    Yes, Arvinas is one of Foghorn Therapeutics’s top competitors.